Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Bakker

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Psychiatry|January 9, 2008
Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactionsP R Bakker, P N van Harten, J van Os
Tijdschrift Voor Psychiatrie|February 12, 2015
[Risk factors for tardive movement disorders in schizophrenia]D E Tenback, P R Bakker, P N van Harten
Tijdschrift Voor Psychiatrie|February 12, 2015
[Movement disorders as a prodromal sign in individuals at high risk of psychosis]P N van Harten, P R Bakker, J van Os
Tijdschrift Voor Psychiatrie|February 12, 2015
[The genetics of antipsychotic-related movement disorders]P R Bakker, J van Os, P N van Harten
Tijdschrift Voor Psychiatrie|March 17, 2016
[Psyche, psychiatric and 'psycho-']J C van der Stel, I E Sommer, P R Bakker
Epidemiology and Psychiatric Sciences|May 1, 2013
Predicting the incidence of antipsychotic-induced movement disorders in long-stay patients: A prospective studyP R Bakker, I W de Groot, J van Os, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 14, 2018
[Sexual dysfunction as a side effect of medication]Anouk van Berkel, Adrie Seldenrijk, H Knegtering, et al.
Epidemiology and Psychiatric Sciences|October 1, 2013
Novel directions for psychiatric diagnosis: from psychopathology to motor function to monitoring technologyP R Bakker, M Wichers, P N van Harten, et al.
Frontiers in Pharmacology|May 17, 2021
Policy and Practice Review: A First Guideline on the Use of Pharmacogenetics in Clinical Psychiatric PracticeR van Westrhenen, R H N van Schaik, T van Gelder, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Psychiatry|January 9, 2008
Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactionsP R Bakker, P N van Harten, J van Os
Tijdschrift Voor Psychiatrie|February 12, 2015
[Risk factors for tardive movement disorders in schizophrenia]D E Tenback, P R Bakker, P N van Harten
Tijdschrift Voor Psychiatrie|February 12, 2015
[Movement disorders as a prodromal sign in individuals at high risk of psychosis]P N van Harten, P R Bakker, J van Os
Tijdschrift Voor Psychiatrie|February 12, 2015
[The genetics of antipsychotic-related movement disorders]P R Bakker, J van Os, P N van Harten
Tijdschrift Voor Psychiatrie|March 17, 2016
[Psyche, psychiatric and 'psycho-']J C van der Stel, I E Sommer, P R Bakker
Epidemiology and Psychiatric Sciences|May 1, 2013
Predicting the incidence of antipsychotic-induced movement disorders in long-stay patients: A prospective studyP R Bakker, I W de Groot, J van Os, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 14, 2018
[Sexual dysfunction as a side effect of medication]Anouk van Berkel, Adrie Seldenrijk, H Knegtering, et al.
Epidemiology and Psychiatric Sciences|October 1, 2013
Novel directions for psychiatric diagnosis: from psychopathology to motor function to monitoring technologyP R Bakker, M Wichers, P N van Harten, et al.
Frontiers in Pharmacology|May 17, 2021
Policy and Practice Review: A First Guideline on the Use of Pharmacogenetics in Clinical Psychiatric PracticeR van Westrhenen, R H N van Schaik, T van Gelder, et al.
Pageof 1